Trial Profile
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectal Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Opiranserin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Vivozon
- 01 Feb 2022 Results of post hoc analysis assessing efficacy and safety of VVZ-149 as a single-use injectable analgesic for treating moderate to severe postoperative pain after colorectal surgery, published in the Journal of Clinical Anesthesia
- 20 May 2017 Results presented at the 36th Annual Scientific Meeting of the American Pain Society
- 20 May 2017 Results presented at the 36th Annual Scientific Meeting of the American Pain Society